Skip to content

Clinical trials

Acute Coronary Syndrome trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Acute Coronary Syndrome Country / region: Russia Clear all

41 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20062
20071
20084
20095
20104
20113
20121
20131
20142
20155
20161
20182
20201
20212
20223
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed31
Unknown status5
Terminated2
Not yet recruiting1
Recruiting1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca4
Tomsk National Research Medical Center of the Russian Academy of Sciences4
Bristol-Myers Squibb3
GlaxoSmithKline3
Samara Regional Cardiology Dispensary3
Sanofi3
Anthera Pharmaceuticals2
Takeda2
AO GENERIUM1
Amarin Pharma Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Acute Coronary Syndrome41
Myocardial Infarction10
Angina, Unstable8
Cardiovascular Diseases6
Heart Diseases4
ST Elevation Myocardial Infarction4
Stroke4
Atherosclerosis3
Coronary Artery Disease3
Coronary Disease3

Trials

Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.